Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Clinical trial NCT06987942 · COMPLETED

Trial details

NCT number: NCT06987942
Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Varicella Influenza Vaccine

Start date: 2024-09-21
Primary completion: 2024-11-15
Enrollment: 899

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.